PFE Earnings & Financial Statements
Pfizer Inc.
$29.21
+$0.84(+2.96%)
70
Overall
100
Value
63
Tech
47
Quality
Market Cap
$161.70B
Volume
39.31M
52W Range
$23.62 - $29.21
Target Price
$29.46
PFE earnings and financial statements: Pfizer Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
PFE Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $62.58B | $63.63B | $59.55B | $100.33B | $81.29B |
| Cost of revenue | $16.07B | $17.85B | $24.95B | $34.34B | $30.82B |
| Operating income | -$41.91B | -$43.51B | -$50.60B | $31.39B | $23.93B |
| EBITDA | $14.11B | $15.04B | $7.35B | $39.79B | $30.79B |
| Net income | $7.77B | $8.03B | $2.12B | $31.37B | $21.98B |
| EPS (diluted) | $1.36 | $1.41 | $0.37 | $5.47 | $3.85 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $208.00B | $213.00B | $227.00B | $197.00B | $181.47B |
| Total liabilities | $121.39B | $124.90B | $137.21B | $101.29B | $103.82B |
| Shareholders’ equity | $86.48B | $88.20B | $89.01B | $95.66B | $77.20B |
| Cash and equivalents | $1.14B | $1.04B | $2.85B | $416.00M | $1.94B |
| Long-term debt | $62.00B | $57.00B | $62.00B | $33.00B | $36.20B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $11.70B | $12.74B | $8.70B | $29.27B | $32.58B |
| Capital expenditure | -$2.63B | -$2.91B | -$3.91B | -$3.24B | -$2.71B |
| Free cash flow | $9.07B | $9.84B | $4.79B | $26.03B | $29.87B |
| Dividends paid | $9.77B | $9.51B | $9.25B | $8.98B | $8.73B |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PFE | $29.21 | +3.0% | 39.31M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |